Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastrointestinal products, such as Carmicide, Cyclopam, Cyclomeff, and Nosic; pain/analgesics products that include Lignox and T-lac; and ophthal/otologicals products, such as Renolen, Homide, Dexoren S, Zincoren, Otorex, Mofloren-D, and Mofloren LP. It also provides vitamins/minerals/nutrients that include Methycal, Cital UTI, SM Fibro, Cal Aid, SM Fibro, MCBM DHA, and Apispur; urology products, such as Carmicide and Cital; Cloben G and Scabex for dermatology; ATM for anti-infectives; Hemsyl for blood related; MCBM 69 and D Chiro for gynecological; and Spear for anti-haemorrhoidal. In addition, the company provides analytical services, such as impurity profile, particle size analysis, heavy metal analysis, polymorphism and compatibility studies, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, it offers services that include architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. The company serves general practitioners, pediatricians, consultant physicians, dentists, cardiologists, diabetologists, endocrinologists, gynaecologists, and ophthalmologists. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.
Indoco Remedies Dividend Announcement
• Indoco Remedies announced a annually dividend of ₹1.50 per ordinary share which will be made payable on 2024-10-26. Ex dividend date: 2024-09-19
• Indoco Remedies annual dividend for 2024 was ₹1.50
• Indoco Remedies annual dividend for 2023 was ₹2.25
• Indoco Remedies's trailing twelve-month (TTM) dividend yield is 0.47%
• Indoco Remedies's dividend growth over the last five years (2018-2023) was 17.61% year
• Indoco Remedies's dividend growth over the last ten years (2013-2023) was 7.42% year
Indoco Remedies Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-09-19 | ₹1.50 | annually | 2024-10-26 |
2023-09-18 | ₹2.25 | annually | 2023-10-26 |
2022-09-14 | ₹0.75 | annually | 2022-10-22 |
2021-09-17 | ₹1.50 | annually | 2021-10-23 |
2020-09-18 | ₹0.30 | annually | 2020-10-24 |
2019-08-22 | ₹0.30 | annually | 2019-09-24 |
2018-08-31 | ₹1.00 | annually | 2018-10-11 |
2017-07-31 | ₹1.60 | annually | 2017-09-08 |
2016-07-20 | ₹0.20 | annually | 2016-08-28 |
2016-03-17 | ₹1.40 | annually | 2016-05-01 |
2015-07-21 | ₹1.60 | annually | 2015-08-29 |
2014-07-18 | ₹1.40 | annually | |
2013-07-19 | ₹1.10 | annually | 2013-08-29 |
Indoco Remedies Dividend per year
Indoco Remedies Dividend growth
Indoco Remedies Dividend Yield
Indoco Remedies current trailing twelve-month (TTM) dividend yield is 0.47%. Interested in purchasing Indoco Remedies stock? Use our calculator to estimate your expected dividend yield:
Indoco Remedies Financial Ratios
Indoco Remedies Dividend FAQ
Other factors to consider when evaluating Indoco Remedies as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Indoco Remedies stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Indoco Remedies's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Indoco Remedies publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Indoco Remedies distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Indoco Remedies are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Indoco Remedies sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Indoco Remedies distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Indoco Remedies declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Indoco Remedies's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Indoco Remedies's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.